USA – Vasa Therapeutics, an Encinitas, CA-based preclinical stage biopharmaceutical company developing novel therapies for cardiovascular aging, closed a Seed funding of $6M supplemented by $2.3M non-dilutive grant funding. The round was led by Orphinic Scientific and included participation from private investments funds NuFund Venture Group, SeedFolio, and others. Orphinic’s chairman of supervisory board, Prof. Jarosław Leszczyszyn, will […]
Archivio Categoria: venture capital funding
03
Gen
Gen
USA – Baird Capital, a Chicago, IL-based investment firm focused on B2B technology & services companies, closed its sixth U.S. venture capital fund with a total of $218M. The fund is anchored by Baird and joined by returning and new institutions, foundations, family offices and industry executives. It will be led by investment partners Joanna Arras, Mark Donnelly, […]
03
Gen
Gen
UK – Robin AI, a London, UK-based provider of an AI-powered legal copilot, raised $26M in Series B funding. The round was led by Temasek. Other investors included QuantumLight, Plural and AFG Partners.The company intends to use the funds to expand its team on the ground in the US where three quarters of its revenue […]
02
Gen
Gen
USA – Dakota Wealth Management, a Palm Beach Gardens, FL-based independent investment management firm, acquired C2C Wealth Management, LLC, an SEC registered investment advisory firm managing approximately $350 million in Mansfield, MA. The amount of the deal was not disclosed.The transaction marks the fourth Dakota has announced since June 1. Previous transactions included Stillwater Investment Management in June, Jonathan […]
02
Gen
Gen
USA – Myers Industries (NYSE: MYE), an Akron, OH-based manufacturer and distributor of industrial products, acquired Signature Systems, a Flower Mound, TX-based company which specializes in composite ground protection solutions, for approximately $350M. With the acquisition, Myers will enhance traditional strength of free cash flow generation. The deal delivers $8M in annualized operational and cost […]
02
Gen
Gen
USA – Traliant, a NYC-based provider of online compliance training solutions, acquired Kantola Training Solutions, a San Francisco, CA-based eLearning company serving over 15,000 organizations. The amount of the deal was not disclosed.Kantola’s training solutions further strengthen Traliant’s portfolio of online compliance training courses. Led by Sarah Rowell, CEO, Kantola is an eLearning company focused on […]
02
Gen
Gen
USA – NewSpring, a Radnor, PA-based family of private equity strategies investing in the lower-middle market, raised over $180M for fourth growth equity healthcare fund, NewSpring Health Capital IV (“NSH IV”). NewSpring Healthcare is a thesis-driven, domain-specific growth equity strategy, with over 20 years of experience investing in companies that help different segments of the […]
USA – Intrinsic, a San Francisco, CA-based startup building AI systems for Trust & Safety teams to keep up with abuse, raised $3.1m in seed funding. Backers included Urban Innovation Fund (leader), Y Combinator, 645 Ventures and Okta and others. The company intends to use the funds to expand operations and its development efforts. Intrinsic is […]
series C, venture capital funding
Apollo Therapeutics Holds USD33.5M Second Close of Series C; Brings Round Total to $260M
02
Gen
Gen
UK – Apollo Therapeutics, a Cambridge, UK and Boston, MA- and and Chicago, IL-based portfolio biopharmaceutical company focused on translating fundamental medical research into medicines, raised USD 33.5M in a second close of its Series C financing. The round, which brought the total amount to $260M, was led by Patient Square Capital and included participation […]
02
Gen
Gen
USA – Heranova Lifesciences, a Burlington, MA-based biotech company for women’s health, raised $13.5M in Seed+ funding. Backers included Pivotal bioVenture Partners China, Sinovation Ventures, Emerging Technology Partners, and Triwise Capital.The company intends to use the funds to launch a serial of non-invasive endometriosis tests and advance two innovative (non-hormonal and non-antibiotic) therapeutic programs for […]